Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rank in Stocks #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Share Price
$4.51
Market Cap
$540.82M
Change (1 day)
-2.42%
Change (1 year)
-43.50%
Country
CN
Trade Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Category

Stock price history for Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Highest end of day price: $4.90 on 2026-08-01

Lowest end of day price: $2.62 on 2017-01-01
Stock price history of Nanjing Hicin Pharmaceutical Co., Ltd. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -8.43%
2025 143.40%
2024 -11.77%
2023 -29.60%
2022 69.07%
2021 -18.98%
2020 -10.68%
2019 -0.37%
2018 22.24%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.82 31.04%
DE
$37.61 25.11%
JP
$219.53 25.89%
CH
$21.18 17.10%
IN